Comprehensive Fatty Acid Profile
$649.00
The Comprehensive Fatty Acid Profile, C8-C26 measures omega-3, omega-6, saturated, monounsaturated and very-long-chain fatty acids, including EPA, DHA, arachidonic acid and markers of essential-fatty-acid deficiency. Useful for patients with Long COVID or post-viral symptoms, fatigue, brain fog, chronic inflammation, metabolic dysfunction, suspected mitochondrial problems, malabsorption, restrictive diets, or poor response to omega-3 supplements. This broad blood test helps identify fatty-acid deficiencies and imbalances so diet and supplementation can be based on measured results rather than guesswork.
Description
Comprehensive Fatty Acid Profile, C8-C26
Fatty acids do much more than store energy. They are structural components of every cell membrane and are involved in brain function, nerve health, inflammation, immune signaling, cardiovascular health and cellular energy metabolism.
The Comprehensive Fatty Acid Profile, C8-C26 measures a broad range of omega-3, omega-6, saturated, monounsaturated and very-long-chain fatty acids. It can identify nutritional deficiencies, unfavorable fatty-acid patterns and unusual abnormalities in the way the body processes fats.
Why Consider This Test?
Many people take fish oil, change their diet or use supplements without ever knowing whether their fatty-acid status is actually adequate. Others have persistent fatigue, brain fog, inflammatory symptoms, metabolic problems or digestive disorders in which abnormal fat intake, absorption or metabolism may be contributing.
This test goes well beyond a simple omega-3 measurement. It examines fatty acids from C8 through C26, providing information about essential-fatty-acid nutrition, omega-3 and omega-6 status, membrane fats and the processing of very-long-chain fatty acids.
The practical advantage: instead of guessing which fats may be needed—or assuming that a supplement is working—the profile can show whether important fatty acids are low, high or unusually distributed and help guide more individualized nutritional and metabolic treatment.
Who May Benefit Most From Fatty Acid Testing?
Long COVID & Post-Viral Illness
Research increasingly suggests that Long COVID can involve altered polyunsaturated-fatty-acid metabolism and inflammatory lipid pathways. Patients with persistent fatigue, brain fog, exercise intolerance or inflammatory symptoms may benefit from evaluating the fatty acids that serve as building blocks for these pathways.
Fatigue & Mitochondrial Dysfunction
Fatty acids are important cellular fuels. In patients with unexplained fatigue, poor exercise tolerance or suspected mitochondrial dysfunction, this profile can complement testing such as acylcarnitines, organic acids and lactate/pyruvate.
Brain Fog, Cognitive & Neurologic Symptoms
DHA, EPA, arachidonic acid and other long-chain fatty acids are major components of brain and nerve-cell membranes. Abnormal levels may identify nutritional or metabolic factors worth correcting or investigating further.
Mood & Mental Health
Omega-3 and omega-6 fatty acids participate in neuronal membrane function and cell signaling. Testing may be useful when nutritional status is being evaluated as part of a broader approach to depression, anxiety, attention problems or other neuropsychiatric symptoms.
Chronic Inflammation & Autoimmune Conditions
EPA, DHA, arachidonic acid and related fats provide the raw materials used to produce many inflammatory and inflammation-resolving signaling molecules. Testing can identify potentially modifiable fatty-acid patterns.
Metabolic & Cardiovascular Health
Insulin resistance, metabolic syndrome, obesity, elevated triglycerides and other metabolic problems can be accompanied by altered fatty-acid patterns. The results can provide information beyond a standard cholesterol panel.
Digestive Disorders & Malabsorption
Chronic intestinal disease, pancreatic or biliary problems, bariatric surgery and other causes of impaired fat absorption can lead to inadequate essential fatty acids even when the diet appears adequate.
Restrictive or Specialized Diets
Very-low-fat diets, elimination diets, vegan or vegetarian diets and other restrictive eating patterns may alter essential-fatty-acid intake. Testing provides an objective measurement rather than relying only on dietary estimates.
Taking Fish Oil or Omega-3 Supplements
Supplement dose does not always predict blood levels. Testing can show whether EPA and DHA are actually improving and whether other fatty-acid abnormalities remain despite supplementation.
Unexplained Nutritional Deficiency
Poor skin health, impaired wound healing, nutritional deficiencies or unexplained symptoms associated with poor intake or absorption may justify a broader assessment of essential fats.
What Does the Comprehensive Fatty Acid Profile Measure?
The panel evaluates dozens of individual fatty acids and several clinically useful totals and ratios. Important groups include:
Omega-3 Fatty Acids
Includes important fats such as EPA, DHA, DPA and alpha-linolenic acid. These fatty acids are involved in cell membranes, brain and cardiovascular function and regulation of inflammatory signaling.
Omega-6 Fatty Acids
Includes linoleic acid, arachidonic acid and related omega-6 fats. These are essential components of membranes and provide substrates for many signaling molecules.
Saturated & Monounsaturated Fats
Includes fatty acids such as palmitic, stearic, oleic and related fats that can reflect both dietary intake and the body's own fat metabolism.
Very-Long-Chain Fatty Acids
Includes fats such as C24:0 and C26:0. Significant elevations may indicate difficulty processing very-long-chain fats and can warrant additional metabolic evaluation.
Phytanic & Pristanic Acids
These specialized fatty acids provide additional information about peroxisomal fat metabolism. Marked abnormalities are uncommon but may be important when identified.
Mead Acid & Triene:Tetraene Ratio
These measurements help identify significant essential-fatty-acid deficiency, which may occur with inadequate intake or severe fat malabsorption.
What Can High or Low Fatty Acids Mean?
| Finding | What It May Mean | How Treatment May Be Individualized |
|---|---|---|
| Low EPA / DHA | May indicate inadequate omega-3 intake, poor absorption or inadequate response to supplementation. | Dietary fatty fish or targeted EPA/DHA supplementation may be considered, followed by reassessment. |
| Low alpha-linolenic acid | May reflect inadequate intake of essential plant-based omega-3 fats. | Dietary sources such as flax, chia, walnuts and selected oils may be increased when appropriate. |
| Unfavorable omega-3 / omega-6 pattern | May indicate that the fatty acids used for membrane and inflammatory signaling are out of balance. | Treatment commonly focuses on improving EPA and DHA status and the overall dietary pattern rather than simply eliminating omega-6 fats. |
| Low linoleic acid | May indicate inadequate essential-fat intake or poor absorption. | Essential-fat intake and possible causes of malabsorption can be evaluated and corrected. |
| High Mead acid or triene:tetraene ratio | Can indicate significant essential-fatty-acid deficiency. | Evaluation focuses on inadequate dietary intake, intestinal absorption, pancreatic or biliary function and appropriate replacement of essential fats. |
| Abnormal arachidonic acid | May reflect altered omega-6 metabolism or an imbalance between inflammatory and inflammation-resolving fatty-acid substrates. | Interpretation is based on the entire fatty-acid pattern rather than treating arachidonic acid alone. |
| High saturated or monounsaturated patterns | Can accompany altered dietary intake, insulin resistance or increased production of fats by the body. | Treatment may include changes in diet, weight management, glucose control, triglyceride reduction and correction of metabolic dysfunction. |
| High C24:0 or C26:0 | May indicate difficulty breaking down certain very-long-chain fatty acids. | Significant elevations generally warrant confirmation and additional metabolic evaluation rather than simply changing dietary fat intake. |
| High phytanic or pristanic acid | May indicate an unusual problem processing specialized dietary fats. | Marked abnormalities may require more specific metabolic investigation and treatment directed at the underlying cause. |
Fatty Acids and Long COVID
Long COVID is increasingly recognized as a multisystem condition that can involve persistent inflammation, altered immune signaling, metabolic dysfunction and impaired recovery after infection.
Recent research has identified abnormalities in the metabolism of essential polyunsaturated fatty acids in patients who developed Long COVID. These include pathways involving EPA, DHA, arachidonic acid and the downstream molecules involved in initiating and resolving inflammation.
A comprehensive fatty-acid profile does not diagnose Long COVID and does not directly measure specialized inflammatory mediators such as resolvins, prostaglandins or leukotrienes. It does, however, measure many of the underlying fatty-acid substrates from which these signaling molecules are made.
Why Test Instead of Simply Taking Fish Oil?
Two people taking the same omega-3 supplement can have very different blood levels. Differences in diet, absorption, dose, metabolism and other nutrients can influence the result.
In addition, fish oil addresses only part of fatty-acid metabolism. A comprehensive profile can reveal abnormalities in omega-6 fats, saturated and monounsaturated fats, essential-fatty-acid deficiency markers and very-long-chain fatty acids that would not be identified by simply measuring—or supplementing—EPA and DHA.
Testing allows treatment to be directed toward the actual pattern found rather than assuming that every patient needs the same fatty-acid supplement.
How This Test Complements Other Metabolic Testing
Fatty-acid testing can be especially informative when combined with other studies evaluating cellular energy production and nutritional status, including:
- Acylcarnitine profile
- Organic acids
- Lactate and pyruvate
- Coenzyme Q10
- Oxidative-stress markers
- Methylation testing
- Vitamin and mineral assessment
- Glucose, insulin and metabolic markers
Together, these tests can help distinguish inadequate nutrient supply from problems involving absorption, cellular energy metabolism or utilization of nutrients.
Lab Test Details
| Test | Fatty Acid Profile, Comprehensive C8-C26 |
| Labcorp Test Number | 070405 |
| CPT | 82725 |
| Method | Gas Chromatography / Mass Spectrometry (GC/MS) |
| Specimen | Serum preferred; plasma acceptable. Specimen requires special frozen handling. |
| Preparation | Overnight fast, generally 12-14 hours. No alcohol for 24 hours before collection. |
| Typical Lab Turnaround | Approximately 5-10 days after the specimen reaches the laboratory. |
Frequently Asked Questions
Is this the same as an Omega-3 Index?
No. An omega-3 index focuses primarily on EPA and DHA. This comprehensive profile evaluates fatty acids across a much broader C8-C26 range, including omega-3, omega-6, saturated, monounsaturated and very-long-chain fatty acids.
Can the test tell me whether I need fish oil?
It can show whether EPA, DHA and other omega-3 fatty acids are low or abnormal. The complete pattern, diet, medical history and current supplementation should be considered when determining whether supplementation is appropriate.
Can I use the test to monitor omega-3 supplements?
Yes. One useful application is determining whether dietary changes or EPA/DHA supplementation are actually changing measured fatty-acid levels.
Is this useful for Long COVID?
It may be useful as part of a broader nutritional and metabolic evaluation. Research has identified altered polyunsaturated-fatty-acid metabolism in Long COVID. This test does not diagnose Long COVID, but it can identify fatty-acid abnormalities that may be relevant to inflammation, cellular membranes and nutritional status.
Why does the test measure very-long-chain fatty acids?
Very-long-chain fatty acids provide information about how certain specialized fats are processed. Significant abnormalities are uncommon, but they can point toward metabolic pathways that require additional investigation.
What happens if something is high or low?
Common abnormalities may be addressed with dietary changes, targeted omega-3 or essential-fat supplementation, or treatment of an underlying absorption or metabolic problem. Unusual elevations in very-long-chain or specialized fatty acids may require additional testing rather than routine supplementation.
Do I need to fast?
Labcorp recommends an overnight fast of approximately 12-14 hours and avoidance of alcohol for 24 hours before collection. Special precautions apply to infants and individuals suspected of having a fatty-acid oxidation disorder.
Should You Consider Ordering This Panel?
This profile is particularly worth considering when symptoms persist despite a generally normal routine laboratory evaluation, when nutritional or metabolic dysfunction is suspected, or when there is a reason to determine whether dietary fats and supplements are actually producing an adequate fatty-acid pattern.
It may be especially useful in patients with Long COVID or post-viral symptoms, persistent fatigue, brain fog, inflammatory illness, metabolic syndrome, cardiovascular risk, digestive or malabsorption disorders, restricted diets, suspected mitochondrial dysfunction or an inadequate response to omega-3 supplementation.
Measure Before You Guess
Fatty acids influence the membranes, signaling systems and energy pathways of nearly every cell in the body. Yet fatty-acid status is rarely measured in routine blood work.
The Comprehensive C8-C26 Fatty Acid Profile provides a much broader picture than simply asking how much fish a person eats or how many milligrams of fish oil are taken each day. It can identify potentially correctable deficiencies and imbalances and, occasionally, reveal unusual patterns that deserve further investigation.
Laboratory testing should be interpreted in the context of symptoms, medical history, diet, medications and supplements. This information is educational and is not intended to diagnose or treat a medical condition without appropriate clinical evaluation.